Globe Life (NYSE:GL) Price Target Lowered to $177.00 at Morgan Stanley

Globe Life (NYSE:GL) had its target price lowered by Morgan Stanley from $179.00 to $177.00 in a report published on Monday,Benzinga reports. The firm currently has an overweight rating on the stock.

Other analysts have also issued research reports about the stock. Weiss Ratings reiterated a “buy (b-)” rating on shares of Globe Life in a research note on Wednesday, October 8th. Wells Fargo & Company decreased their target price on shares of Globe Life from $172.00 to $170.00 and set an “overweight” rating for the company in a research note on Friday, October 24th. Cfra Research raised shares of Globe Life to a “moderate buy” rating in a research note on Friday, July 25th. BMO Capital Markets reiterated a “market perform” rating and issued a $149.00 price objective (up previously from $114.00) on shares of Globe Life in a report on Wednesday, July 30th. Finally, Truist Financial upped their price objective on shares of Globe Life from $150.00 to $158.00 and gave the company a “buy” rating in a research report on Friday, October 24th. Eight investment analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company’s stock. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $153.33.

Globe Life Trading Down 0.4%

Shares of GL opened at $131.26 on Monday. Globe Life has a 12 month low of $100.27 and a 12 month high of $147.83. The stock’s 50-day moving average is $137.27 and its two-hundred day moving average is $130.93. The company has a debt-to-equity ratio of 0.43, a current ratio of 0.06 and a quick ratio of 0.06. The stock has a market cap of $10.45 billion, a PE ratio of 9.51 and a beta of 0.55.

Globe Life (NYSE:GL) last posted its earnings results on Wednesday, October 22nd. The company reported $4.81 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $4.54 by $0.27. The business had revenue of $1.51 billion during the quarter, compared to analyst estimates of $1.52 billion. Globe Life had a return on equity of 22.12% and a net margin of 19.36%.During the same quarter last year, the firm earned $3.44 earnings per share. Globe Life has set its FY 2026 guidance at 14.600-15.300 EPS. FY 2025 guidance at 14.400-14.600 EPS. Equities analysts forecast that Globe Life will post 13.87 earnings per share for the current fiscal year.

Globe Life Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, January 30th. Investors of record on Monday, January 5th will be issued a $0.27 dividend. The ex-dividend date of this dividend is Monday, January 5th. This represents a $1.08 annualized dividend and a yield of 0.8%. Globe Life’s dividend payout ratio is currently 7.83%.

Institutional Investors Weigh In On Globe Life

Several hedge funds and other institutional investors have recently modified their holdings of the stock. Global Assets Advisory LLC bought a new position in shares of Globe Life during the second quarter worth about $25,000. AdvisorNet Financial Inc raised its stake in Globe Life by 60.0% during the second quarter. AdvisorNet Financial Inc now owns 224 shares of the company’s stock valued at $28,000 after buying an additional 84 shares in the last quarter. Mather Group LLC. bought a new position in Globe Life during the 3rd quarter worth approximately $28,000. CYBER HORNET ETFs LLC acquired a new position in shares of Globe Life in the 2nd quarter worth approximately $28,000. Finally, Assetmark Inc. increased its holdings in shares of Globe Life by 777.8% in the 2nd quarter. Assetmark Inc. now owns 237 shares of the company’s stock valued at $29,000 after acquiring an additional 210 shares during the last quarter. Institutional investors own 81.61% of the company’s stock.

About Globe Life

Globe Life Inc, through its subsidiaries, provides various life and supplemental health insurance products, and annuities to lower middle- and middle-income families in the United States. The company operates in four segments: Life Insurance, Supplemental Health Insurance, Annuities, and Investments.